Psychedelics Psyence BioMed invests half a million into natural psychedelics operator PsyLabs In conjunction with the financing, Psyence has secured the option to receive a steady supply of ibogaine from PsyLabs Rowan DunneApril 16, 2025
Psychedelics Synthetic ibogaine: a game changer for mental health treatment Scientists at UC Davis are making a short supply of the African iboga shrub a less significant problem Rowan DunneFebruary 13, 2025
Psychedelics Psychedelic drug developer MindMed set for listing on Nasdaq Biotechnology Index MindMed's lead drug candidate is an LSD-like therapeutic used to treat anxiety Rowan DunneDecember 20, 2024
Psychedelics Google co-founder invests millions in ibogaine research startup Soneira Sergey Brin's Catalyst4 fund, created with capital from his former Tesla stake, will inject over C$20.5 million Rowan DunneJuly 22, 2024
Psychedelics Terran Biosciences obtains U.S. patent approval for catalogue of novel psychedelics They include two new forms of psilocybin, orally active DMT and 5-MeO-DMT, and an ibogaine derivative Rowan DunneDecember 11, 2023
Psychedelics Kentucky to invest US$42M in psychedelics research for opioid use disorders The money will come from the state's opioid settlement funds and the research will focus on ibogaine Rowan DunneJune 5, 2023
Psychedelics Colorado votes to decriminalize use and possession of natural psychedelics It also introduces state-regulated 'healing centers' where trained facilitators can offer psychedelic-assisted sessions Natalia Buendia CalvilloDecember 29, 2022
Psychedelics Beond publishes ‘Ibogaine: A Clinical Summary’ Mexican clinical practice releases 'most complete and up-to-date known summary' regarding plant-derived psychoactive substance Rowan DunneAugust 31, 2022
Business Universal Ibogaine hires ex-Canopy research director ahead of clinical trial application The firm owns rights to a treatment protocol used at a popular clinic in Cancun, Mexico Natalia Buendia CalvilloMarch 23, 2022
News California Senate passes psychedelic decriminalization bill If Bill SB-519 passes, possession of psychedelics for personal would be decriminalized, but cultivation and sale is still outlawed Natalia Buendia CalvilloJune 2, 2021